Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Ryan, Charles J, Prof ; Smith, Matthew R, Prof ; Fizazi, Karim, Prof ; Saad, Fred, Prof ; Mulders, Peter F A, Prof ; Sternberg, Cora N, MD ; Miller, Kurt, Prof ; Logothetis, Christopher J, Prof ; Shore, Neal D, MD ; Small, Eric J, Prof ; Carles, Joan, MD ; Flaig, Thomas W, MD ; Taplin, Mary-Ellen, MD ; Higano, Celestia S, Prof ; de Souza, Paul, Prof ; de Bono, Johann S, Prof ; Griffin, Thomas W, MD ; De Porre, Peter, MD ; Yu, Margaret K, MD ; Park, Youn C, PhD ; Li, Jinhui, PhD ; Kheoh, Thian, PhD ; Naini, Vahid, PharmD ; Molina, Arturo, MD ; Rathkopf, Dana E, MD

The lancet oncology, 2015-02, Vol.16 (2), p.152-160 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível